Adaptimmune Therapeutics
ADAP
#4046
Rank
$0.89 B
Marketcap
๐Ÿ‡ฌ๐Ÿ‡ง UK
Country
$5.76
Share price
0.17%
Change (1 day)
N/A
Change (1 year)

Market capitalization of Adaptimmune Therapeutics (ADAP)

Market cap: $0.89 Billion

As of September 2021 Adaptimmune Therapeutics has a market cap of $0.89 Billion. This makes Adaptimmune Therapeutics the world's 4046th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.

Market cap history of Adaptimmune Therapeutics from 2015 to 2021

Year Market cap Change
2021$0.80 B-40.78%
2020$1.35 B975.66%
2019$0.12 B-79.01%
2018$0.60 B-3.92%
2017$0.62 B118.3%
2016$0.28 B-66.42%
2015$0.85 B